How are ECRs supported? Overview of global policy approaches
New paper published in Alzheimer’s & Dementia explores how Dementia ECRs are supported in G20 country goverment / charity dementia policies and plans.
New paper published in Alzheimer’s & Dementia explores how Dementia ECRs are supported in G20 country goverment / charity dementia policies and plans.
NIH blog flagging significant future adjustments on the horizon for NIH peer review for applications – ensure you’re on top of what’s to come
Noortje Marres, Carrie Friese and Rachel Coldicutt deliver the annual NCRM lecture exploring the use of AI in Social Research and challenges
Catch-up on this Seminar and hear from international experts on recent discoveries and promising pathways to understand, monitor and treat movement disorders.
With FDA Approval for Donanemab confirmed, it now has a new name…. welcome to Kisunla™ for the Treatment of Early Symptomatic Alzheimer’s Disease.
Discover the latest updates in Alzheimer’s diagnosis & staging with revised criteria. Incorporating biomarkers, this framework bridges research & clinical care.
MND Scotland has announced funding for a pioneering research project that could change the way motor neuron disease (MND) is diagnosed and monitored.
Each year on 21 June the MND community from around the world marks Global MND Awareness Day – a date selected because it marks the longest day of the year.
In this show The Naked Scientists explore the mechanisms of motor neurone disease with John Ealing from the Manchester MND Care Centre.
NIA Webinar exploring Risk for Alzheimer’s Disease Across Diverse Populations: Lessons Learned, Opportunities to Advance Science, and Recent Findings in HABS-HD
Explore the IDEAL Study Living with Dementia Maps: essential tools designed from 80+ studies to enhance service planning and delivery of dementia services
Surprising new research from the UKDRI reveals that contrary to previous understanding, the brain’s ability to rid itself of toxins may be reduced during sleep